Insider Selling: Microbix Biosystems Inc. (TSE:MBX) Director Sells 200,000 Shares of Stock

Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Stock Performance

MBX stock traded down C$0.02 during trading on Thursday, reaching C$0.50. 375,883 shares of the stock were exchanged, compared to its average volume of 308,273. Microbix Biosystems Inc. has a twelve month low of C$0.29 and a twelve month high of C$0.52. The company has a market capitalization of C$68.35 million, a P/E ratio of 12.50 and a beta of 0.34. The stock has a 50 day simple moving average of C$0.37 and a 200-day simple moving average of C$0.35. The company has a current ratio of 6.62, a quick ratio of 5.57 and a debt-to-equity ratio of 22.68.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.